In Tennessee, the patients first in line for the monoclonal antibody Covid-19 treatment are likely to be the ones who landed in the emergency room because they did not get vaccinated.
Extraordinary demand coupled with the federal government’s need to cap shipments of these scarce drugs has forced Tennessee health officials to recommend limiting the treatment to unvaccinated patients with the worst cases of Covid-19.
The bright side is many companies will step up ti manufacture the items.